Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,928 | -94,659 | -69,192 | -40,545 | -19,915 |
| Depreciation Amortization | 92 | 305 | 213 | 123 | 47 |
| Accounts payable and accrued liabilities | -297 | -109 | -1,358 | -657 | 317 |
| Other Working Capital | -1,262 | 2,539 | -4,252 | 276 | -13 |
| Other Operating Activity | 3,658 | 12,960 | 10,875 | 6,837 | 2,603 |
| Operating Cash Flow | $-25,737 | $-78,964 | $-63,714 | $-33,966 | $-16,961 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | -72 | -40 | -40 | N/A |
| Investing Cash Flow | $-62 | $-72 | $-40 | $-40 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,845 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 190,220 | 79,808 | 56,851 | 20,693 | 20,580 |
| Financing Cash Flow | $195,065 | $79,808 | $56,851 | $20,693 | $20,580 |
| Exchange Rate Effect | N/A | -78 | -84 | -52 | -16 |
| Beginning Cash Position | 105,049 | 104,355 | 104,355 | 104,355 | 104,355 |
| End Cash Position | 274,315 | 105,049 | 97,368 | 90,990 | 107,958 |
| Net Cash Flow | $169,266 | $694 | $-6,987 | $-13,365 | $3,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,737 | -78,964 | -63,714 | -33,966 | -16,961 |
| Capital Expenditure | -62 | -72 | -40 | -40 | N/A |
| Free Cash Flow | -25,799 | -79,036 | -63,754 | -34,006 | -16,961 |